Drug Profile
Lymphocyte activation gene 3
Alternative Names: LAG-3Latest Information Update: 03 Nov 2021
Price :
$50
*
At a glance
- Originator Merck Serono
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Transplant rejection
Most Recent Events
- 01 Mar 2000 Suspended-Preclinical for Autoimmune disorders in USA (Parenteral)
- 01 Mar 2000 Suspended-Preclinical for Transplant rejection in USA (Parenteral)
- 08 Dec 1998 Preclinical development for Autoimmune disorders in USA (Unknown route)